Clinical Trial

Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy

Recruiting
View on ClinicalTrials.gov →
Summary
Observational study to evaluate the safety of immunotherapy as a treatment for Hymenoptera venom allergy, analyzing the adverse reaction to immunotherapy as well as the allergic reaction to a spontaneous hymenoptera sting. This study will be conducted in Spain (multicentric) and data will be collected prospectively.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-16.
Trial Details
NCT Number NCT06782217
Lead Sponsor Inmunotek S.L.
Conditions Allergy, Insect Venom, Allergy Insect Stinging, Insect Sting Allergy
Enrollment 120 participants
Start Date 2024-09-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-04